Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study. [PDF]
Xi P +6 more
europepmc +1 more source
Multiparametric MRI to Predict Response to Irreversible Electroporation Plus Anti-PD-1 Immunotherapy in Pancreatic Ductal Adenocarcinoma. [PDF]
Cao Q +9 more
europepmc +1 more source
Pancreatic Tissue Remodeling and Fibrosis After Irreversible Electroporation: A Histopathological and Thermal Perspective. [PDF]
Kim HB, Youm JY, Yang JM, Sim SB.
europepmc +1 more source
High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial. [PDF]
He BM +9 more
europepmc +1 more source
Impact of Voltage on the Production on Spherical Ablations for Integrated Time Nanosecond Pulse Irreversible Electroporation. [PDF]
Williamson RH +7 more
europepmc +1 more source
Hypertension and tachycardia induced by irreversible electroporation in pancreatic cancer: An analysis based on clinical data. [PDF]
Li HM +5 more
europepmc +1 more source
Erratum: Diffusion MRI biomarkers predict the outcome of irreversible electroporation in a pancreatic tumor mouse model. [PDF]
Figini M +13 more
europepmc +1 more source
Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation. [PDF]
Xia ZY +6 more
europepmc +1 more source
Sequential nimotuzumab plus gemcitabine and nab-paclitaxel chemotherapy followed by irreversible electroporation in advanced pancreatic ductal adenocarcinoma: a retrospective real-world analysis. [PDF]
Liu Y +12 more
europepmc +1 more source
Real-world safety of irreversible electroporation therapy for tumors with nanoknife: MAUDE database analysis. [PDF]
Xiang JC +4 more
europepmc +1 more source

